Anti-PD-L1 antibody [EPR20529]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
5
(5 Reviews)
|
(131 Publications)
Anti-PD-L1 antibody [EPR20529] (ab213480) is a rabbit monoclonal antibody detecting PD-L1 in Western Blot, IP, ICC/IF. Suitable for Mouse.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 70 publications
View Alternative Names
CD274, B7h1, Pdcd1l1, Pdcd1lg1, Pdl1, Cd274, Programmed cell death 1 ligand 1, PD-L1, PDCD1 ligand 1, Programmed death ligand 1, B7 homolog 1, B7-H1
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-PD-L1 antibody [EPR20529] (AB213480)
ab213480 staining PD-L1 in RAW264.7 from Mouse macrophage cell line transformed with Abelson murine leukemia virus by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with 100% Methanol. Samples were incubated with ab213480 at 0.4 μg/ml. AlexaFluor®488 Goat anti-Rabbit (ab150077) was used as the secondary antibody at 2 μg/ml. Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)(ab196889) was used as counterstain at 2.5 μg/ml. DAPI used as nuclear counterstain. Confocal image showing membranous staining on RAW 264.7 cells treated with IFN-γ (100 ng/ml) for 24 hours.
- IP
Supplier Data
Immunoprecipitation - Anti-PD-L1 antibody [EPR20529] (AB213480)
PD-L1 was immunoprecipitated from 0.35 mg of Mouse placenta lysate with ab213480 at 1/30 dilution.
Western blot was performed from the immunoprecipitate using ab213480 at 1/500 dilution.
VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1,000 dilution.
Lane 1 : Mouse placenta lysate, 10 μg (Input).
Lane 2 : ab213480 IP in mouse placenta lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab213480 in mouse placenta lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 seconds.
All lanes:
Immunoprecipitation - Anti-PD-L1 antibody [EPR20529] (ab213480)
Predicted band size: 33 kDa
Observed band size: 55-60 kDa
false
- WB
Supplier Data
Western blot - Anti-PD-L1 antibody [EPR20529] (AB213480)
Blocking/Dilution buffer : 5% NFDM/TBST.
The molecular weight observed is consistent with what has been described in the literature. PMID : 15353579.
All lanes:
Western blot - Anti-PD-L1 antibody [EPR20529] (ab213480) at 1/1000 dilution
All lanes:
Mouse placenta lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 33 kDa
Observed band size: 40-60 kDa
false
Exposure time: 15s
- WB
Lab
Western blot - Anti-PD-L1 antibody [EPR20529] (AB213480)
This WB was performed by using YCA-R20529(BF)-111A H3L2 YR120921PJ, 1 : 5000 dilution. Working concentration : 0.402 μg/ml.
Blocking buffer and concentration : 5% NFDM/TBST
Diluting buffer and concentration : 5% NFDM/TBST
All lanes:
Western blot - Anti-PD-L1 antibody [EPR20529] (ab213480) at 1/5000 dilution
Lane 1:
Untreated RAW264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Lane 2:
RAW264.7 treated with 100 ng/ml IFN gamma for 48 h, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 33 kDa
Observed band size: 40-60 kDa
false
Exposure time: 37s
- WB
AbReview78135****
Western blot - Anti-PD-L1 antibody [EPR20529] (AB213480)
The mAb is specific for mouse mPDL1 and does not recognise hPDL1. As expected a specific 48kDa band is observed in RAW264.7 and MEFS cell extract after Interferon-gamma treatment. No bands are observed in RAW264.7 and MEFS WT and in MEFS KO with and without Interferon-gamma treatment.
All lanes:
Western blot - Anti-PD-L1 antibody [EPR20529] (ab213480) at 100 µg
Lane 1:
HEK mPDL1 cell lysate at 20 µg
Lane 2:
HEK hPDL1 cell lysate at 20 µg
Lane 3:
HEK CL7 at 20 µg
Lane 4:
RAW 264.7 Wild-type (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 100 µg
Lane 5:
RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate treated with Interferon-gamma at 100 µg
Lane 6:
MEF Wild-type (Mouse embryonic fibroblast cell line) whole cell lysate at 100 µg
Lane 7:
MEF (Mouse embryonic fibroblast cell line) whole cell lysate treated with Interferon-gamma at 100 µg
Lane 8:
MEF mPDL1 KO cell lysate at 100 µg
Lane 9:
MEF mPDL1 KO treated with Interferon-gamma at 100 µg
Predicted band size: 33 kDa
Observed band size: 48 kDa
false
Exposure time: 5min
This image is courtesy of an anonymous collaborator.
Related conjugates and formulations (1)
-
Anti-PD-L1 antibody [EPR20529] - BSA and Azide free
Reactivity data
Product details
Anti-PD-L1 antibody [EPR20529] (ab213480) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ICC/IF, IP and WB.
Abcam's high quality manufacturing and validation processes ensure Anti-PD-L1 antibody [EPR20529] (ab213480) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-PD-L1 antibody [EPR20529] (ab213480) has been confirmed by Western Blot testing in PD-L1 knockout MEF (mouse embryonic fibroblast) cells.
Anti-PD-L1 antibody [EPR20529] (ab213480) has 5 independent reviews from customers.
Anti-PD-L1 antibody [EPR20529] (ab213480) specifically detects PD-L1 (UniProt ID: Q9EP73; Molecular weight: 31kDa) and is sold in 100 µL and 1 mL selling sizes.
Conjugation-ready, carrier free format available for antibody clone EPR20529 - ab223141.
Programmed death-ligand 1 (PD-L1) is a critical protein in immuno-oncology, playing a significant role in tumor immune evasion. It is expressed on the surface of tumor cells and binds to the PD-1 receptor on T cells, inhibiting their activity and allowing tumors to escape immune detection.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PD-L1 plays a central role in immune evasion mechanisms utilized by tumors. It is not part of a larger protein complex but directly interacts with PD-1 and CD80. When PD-L1 binds to PD-1 it sends inhibitory signals leading to decreased T cell activation and proliferation allowing cancer cells to avoid immune destruction. PD-L1 expression provides a mechanism for tumors to suppress immune surveillance facilitating tumor progression.
Pathways
PD-L1 is integral to the immune checkpoint pathway which is an important regulator of immune response. The interaction between PD-L1 and PD-1 provides a mechanism for immune tolerance which is part of the broader adaptive immune system pathway. PD-L1 is related to other immune checkpoint proteins such as CTLA-4 in its function to limit autoreactivity and promote immune homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (131)
Recent publications for all applications. Explore the full list and refine your search
Journal of nanobiotechnology 23:648 PubMed41074162
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:8804 PubMed41038820
2025
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasia (New York, N.Y.) 69:101222 PubMed40882404
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 23:374 PubMed40836297
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal for immunotherapy of cancer 13: PubMed40789740
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer management and research 17:1503-1512 PubMed40727589
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:4564 PubMed40379682
2025
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e04860 PubMed40364727
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature genetics 57:680-693 PubMed40069506
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cells 14: PubMed39996786
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com